Finance

Lists
002332:SHE
Zhejiang Xianju Pharmaceutical Co Ltd
CN¥8.89
+0.34%
(+0.030) 1D
Oct 30, 3:04:24 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002332...
Open
CN¥8.81
High
CN¥8.98
Low
CN¥8.80
Mkt. cap
8.79B
Avg. vol.
13.58M
Volume
13.95M
Dividend
3.37%
Quarterly dividend
CN¥0.08
Ex-dividend date
Sep 16, 2026
P/E ratio
18.81
52-wk high
CN¥10.05
52-wk low
CN¥7.92
EPS
CN¥0.47
Shares outstanding
989.20M
No. of employees
3K
Open
CN¥8.81
High
CN¥8.98
Low
CN¥8.80
Mkt. cap
8.79B
Avg. vol.
13.58M
Volume
13.95M
Dividend
3.37%
Quarterly dividend
CN¥0.08
Ex-dividend date
Sep 16, 2026
P/E ratio
18.81
52-wk high
CN¥10.05
52-wk low
CN¥7.92
EPS
CN¥0.47
Shares outstanding
989.20M
No. of employees
3K
News stories
From web sources and news partners
About Zhejiang Xianju Pharmaceutical Co Ltd
CEO-
Employees3.21K
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
933.39M
918.35M
1.04B
969.74M
Cost of goods sold
431.84M
372.24M
387.92M
359.97M
Cost of revenue
431.84M
372.24M
387.92M
359.97M
Research and development expenses
105.33M
69.00M
51.53M
55.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
401.84M
358.84M
387.70M
391.10M
Operating expense
521.61M
433.08M
455.99M
428.73M
Total operating expenses
953.45M
805.32M
843.91M
788.69M
Operating income
-20.06M
113.03M
196.38M
181.04M
Other non operating income
7.42M
-6.08M
9.58M
56.91M
EBT including unusual items
78.49M
108.30M
181.44M
214.66M
EBT excluding unusual items
-13.00M
108.54M
199.76M
242.55M
Income tax expense
21.76M
17.93M
27.23M
40.58M
Effective tax rate
27.72%
16.56%
15.01%
18.90%
Other operating expenses
14.84M
3.17M
8.72M
-7.30M
Net income
42.96M
93.89M
150.67M
177.66M
Net profit margin
4.60%
10.22%
14.48%
18.32%
Earnings per share
-
-
-
-
Interest and investment income
4.04M
2.32M
3.99M
1.35M
Interest expense
-1.42M
-725.41K
-626.06K
-6.32M
Net interest expenses
2.62M
1.60M
3.37M
-4.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
33.50M
166.59M
252.42M
234.60M
Gain or loss from assets sale
-46.30M
-
107.13K
-107.13K
Upcoming events
AI content may include mistakes. Learn more
Google apps